Accolade (NASDAQ: ACCD) shares advanced almost 13% in premarket Friday trading after the healthcare software firm offered a better-than-expected outlook ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE